Azenta (AZTA) Cash & Current Investments (2010 - 2026)
Azenta's (AZTA) quarterly Cash & Current Investments came in at $236.4 million in Q1 2026, down 7.55% year-on-year from $255.7 million in Q1 2025, and down 30.26% on a QoQ basis from $339.0 million in Q4 2025.
Azenta (AZTA) Cash & Current Investments (2010 - 2026) Analysis & Trends
Azenta (AZTA) has 17 years of Cash & Current Investments data on file, last reported at $236.4 million in Q1 2026.
- On a quarterly basis, Cash & Current Investments fell 7.55% year-over-year to $236.4 million in Q1 2026; TTM through Mar 2026 was $236.4 million, a 7.55% decrease from a year earlier, with the FY2025 full-year figure at $339.0 million, changed N/A from the prior year.
- Cash & Current Investments for Q1 2026 stood at $236.4 million, down from $339.0 million in the prior quarter.
- Over the last five years, Cash & Current Investments for AZTA reached as high as $2.8 billion in Q1 2022 and fell as low as $236.4 million in Q1 2026.
- Historically, Cash & Current Investments has averaged $799.6 million across 5 years, with a median of $595.8 million in 2024.
- Across the five-year window, Cash & Current Investments jumped 759.7% in 2022 and plunged 69.81% in 2024, its largest moves.
- Year by year, Cash & Current Investments stood at $1.1 billion in 2022, then slumped by 37.44% to $707.7 million in 2023, then sank by 46.37% to $379.6 million in 2024, then retreated by 10.68% to $339.0 million in 2025, then slumped by 30.26% to $236.4 million in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $236.4 million in Q1 2026, $339.0 million in Q4 2025, and $340.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.58 Bn | 121.36 Bn | 1.96 Bn | 5.22 Bn |
| 2 | Becton Dickinson | 44.90 Bn | 44.08 Bn | 2.15 Bn | 816.00 Mn |
| 3 | Alcon | 32.95 Bn | 31.29 Bn | 1.53 Bn | 1.66 Bn |
| 4 | Medline | 32.83 Bn | 30.59 Bn | 1.84 Bn | 2.24 Bn |
| 5 | Resmed | 29.38 Bn | 27.72 Bn | 890.98 Mn | 1.66 Bn |
| 6 | West Pharmaceutical Services | 23.41 Bn | 22.98 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 14.08 Bn | 13.52 Bn | 1.10 Bn | 561.00 Mn |
| 8 | Cooper Companies | 13.79 Bn | 13.66 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 1.06 Bn |
| 10 | Azenta | 1.27 Bn | 1.03 Bn | 125.74 Mn | 236.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 236.44 Mn |
| Dec 31, 2025 | 339.02 Mn |
| Sep 30, 2025 | 340.92 Mn |
| Jun 30, 2025 | 272.35 Mn |
| Mar 31, 2025 | 255.74 Mn |
| Dec 31, 2024 | 379.57 Mn |
| Sep 30, 2024 | 431.19 Mn |
| Jun 30, 2024 | 595.84 Mn |
| Mar 31, 2024 | 356.58 Mn |
| Dec 31, 2023 | 707.72 Mn |
| Sep 30, 2023 | 654.13 Mn |
| Jun 30, 2023 | 734.35 Mn |
| Mar 31, 2023 | 1.18 Bn |
| Dec 31, 2022 | 1.13 Bn |
| Sep 30, 2022 | 1.04 Bn |
| Jun 30, 2022 | 2.18 Bn |
| Mar 31, 2022 | 2.75 Bn |
| Dec 31, 2021 | 215.22 Mn |
| Sep 30, 2021 | 234.57 Mn |
| Jun 30, 2021 | 269.96 Mn |